|Articles|May 1, 2007
- Pharmaceutical Executive-05-01-2007
- Volume 0
- Issue 0
The Pharm Exec 50: Holding Pattern
The top 50 pharmaceutical companies, ranked by prescription pharmaceutical drug sales, plus rankings of top products, R&D spend, and more.
Advertisement
Articles in this issue
over 19 years ago
Kid Tested, Government Approved?over 19 years ago
Leadership: Getting on Boardover 19 years ago
Spend Trends 2007: Hang 10over 19 years ago
The Secretover 19 years ago
Marketing to Professionals: No Sales Force, No Problemover 19 years ago
Opinion: Are Price Controls the New Black?over 19 years ago
Toolkit: How To Be a Better Partnerover 19 years ago
Washington Report: Pathways for Proteinsover 19 years ago
Global Report: Pure and Simpleover 19 years ago
Thoughtleader: Thomas Nagle, Monitor GroupAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb
2
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
3
Who Pays for Tariff Driven Input Cost Increases?
4
The Shift Towards Globally Sourced Innovation
5